Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 7 | 2007 | 72 | 0.950 |
Why?
|
| Optic Nerve Diseases | 5 | 2004 | 31 | 0.750 |
Why?
|
| Vision Disorders | 6 | 2007 | 94 | 0.670 |
Why?
|
| Optic Atrophies, Hereditary | 4 | 2000 | 4 | 0.660 |
Why?
|
| Genetic Linkage | 6 | 2001 | 90 | 0.660 |
Why?
|
| X Chromosome | 4 | 2001 | 28 | 0.570 |
Why?
|
| Neurites | 2 | 2007 | 18 | 0.560 |
Why?
|
| Visual Fields | 6 | 2004 | 41 | 0.500 |
Why?
|
| Nystagmus, Pathologic | 3 | 1999 | 12 | 0.470 |
Why?
|
| Eye Diseases | 2 | 2003 | 38 | 0.430 |
Why?
|
| Optic Neuropathy, Ischemic | 4 | 2007 | 6 | 0.410 |
Why?
|
| Visual Acuity | 9 | 2003 | 236 | 0.370 |
Why?
|
| Point Mutation | 3 | 2000 | 97 | 0.360 |
Why?
|
| Optic Nerve | 6 | 2001 | 55 | 0.350 |
Why?
|
| Retinal Detachment | 3 | 1997 | 14 | 0.330 |
Why?
|
| DNA, Mitochondrial | 4 | 2005 | 84 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1998 | 20 | 0.300 |
Why?
|
| Vitrectomy | 2 | 1997 | 21 | 0.300 |
Why?
|
| Nystagmus, Congenital | 2 | 2007 | 2 | 0.290 |
Why?
|
| Anthrax Vaccines | 2 | 2006 | 5 | 0.280 |
Why?
|
| Optic Neuritis | 2 | 2006 | 26 | 0.280 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 75 | 0.260 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2005 | 2 | 0.260 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 43 | 0.260 |
Why?
|
| Toxins, Biological | 1 | 2004 | 23 | 0.250 |
Why?
|
| Eye Proteins | 1 | 2005 | 160 | 0.250 |
Why?
|
| Pupil Disorders | 2 | 2001 | 3 | 0.240 |
Why?
|
| Pedigree | 6 | 2001 | 159 | 0.240 |
Why?
|
| Blepharospasm | 1 | 2003 | 1 | 0.240 |
Why?
|
| Diabetic Retinopathy | 3 | 2009 | 109 | 0.240 |
Why?
|
| Cranial Nerve Diseases | 1 | 2003 | 14 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 785 | 0.230 |
Why?
|
| Serpins | 1 | 2005 | 205 | 0.230 |
Why?
|
| Pituitary Neoplasms | 2 | 2000 | 52 | 0.230 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 148 | 0.220 |
Why?
|
| Glucose | 1 | 2003 | 307 | 0.210 |
Why?
|
| Ophthalmology | 2 | 2000 | 39 | 0.200 |
Why?
|
| Neurology | 2 | 2000 | 43 | 0.200 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2000 | 7 | 0.190 |
Why?
|
| Nerve Compression Syndromes | 1 | 2000 | 16 | 0.190 |
Why?
|
| Visual Pathways | 1 | 2000 | 31 | 0.190 |
Why?
|
| Molecular Biology | 2 | 1997 | 31 | 0.190 |
Why?
|
| Humans | 35 | 2009 | 68525 | 0.190 |
Why?
|
| Axons | 1 | 2001 | 139 | 0.190 |
Why?
|
| Vaccination | 1 | 2002 | 182 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 142 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1999 | 17 | 0.180 |
Why?
|
| Adenoma | 1 | 2000 | 132 | 0.180 |
Why?
|
| Genetic Heterogeneity | 1 | 1999 | 11 | 0.180 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1293 | 0.180 |
Why?
|
| Nerve Fibers | 4 | 2005 | 77 | 0.160 |
Why?
|
| Eye Diseases, Hereditary | 1 | 1997 | 10 | 0.160 |
Why?
|
| Evoked Potentials, Visual | 1 | 1998 | 18 | 0.160 |
Why?
|
| Retina | 3 | 2009 | 252 | 0.160 |
Why?
|
| Pituitary Diseases | 1 | 1997 | 4 | 0.150 |
Why?
|
| Sella Turcica | 1 | 1997 | 10 | 0.150 |
Why?
|
| Retinal Diseases | 2 | 1995 | 40 | 0.150 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1997 | 16 | 0.150 |
Why?
|
| Adult | 14 | 2009 | 21375 | 0.150 |
Why?
|
| Acute Disease | 4 | 2005 | 658 | 0.150 |
Why?
|
| Male | 20 | 2006 | 37281 | 0.140 |
Why?
|
| Genes, Dominant | 1 | 1996 | 51 | 0.140 |
Why?
|
| Scleral Buckling | 1 | 1996 | 1 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2007 | 1139 | 0.140 |
Why?
|
| Cataract Extraction | 1 | 1997 | 127 | 0.140 |
Why?
|
| Cell Separation | 2 | 2007 | 132 | 0.140 |
Why?
|
| Brain | 2 | 2003 | 2175 | 0.140 |
Why?
|
| Aged | 12 | 2003 | 14842 | 0.130 |
Why?
|
| Phacoemulsification | 1 | 1996 | 69 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 189 | 0.130 |
Why?
|
| Macular Edema | 3 | 2009 | 21 | 0.130 |
Why?
|
| Female | 17 | 2006 | 38015 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2000 | 805 | 0.120 |
Why?
|
| Cell Count | 2 | 2005 | 248 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2003 | 4843 | 0.110 |
Why?
|
| Visual Field Tests | 2 | 2003 | 8 | 0.110 |
Why?
|
| Multiple Sclerosis | 1 | 1994 | 132 | 0.110 |
Why?
|
| Smoking | 1 | 2000 | 1449 | 0.110 |
Why?
|
| Middle Aged | 12 | 2009 | 21119 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2007 | 188 | 0.100 |
Why?
|
| Lod Score | 2 | 2001 | 14 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 219 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 2083 | 0.100 |
Why?
|
| Hyperglycemia | 2 | 2009 | 158 | 0.090 |
Why?
|
| Genotype | 2 | 2005 | 785 | 0.090 |
Why?
|
| Animals | 6 | 2009 | 20877 | 0.090 |
Why?
|
| Blindness | 2 | 2009 | 22 | 0.090 |
Why?
|
| Blood Glucose | 2 | 2009 | 631 | 0.080 |
Why?
|
| DNA | 2 | 2001 | 597 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 492 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 183 | 0.080 |
Why?
|
| Genetic Markers | 2 | 1999 | 144 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2003 | 3702 | 0.080 |
Why?
|
| Rats | 2 | 2007 | 5300 | 0.080 |
Why?
|
| Haplotypes | 2 | 1999 | 174 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 24 | 0.080 |
Why?
|
| Atrophy | 3 | 2000 | 112 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2007 | 144 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 108 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 510 | 0.070 |
Why?
|
| Thy-1 Antigens | 1 | 2005 | 4 | 0.070 |
Why?
|
| Tetracyclines | 1 | 2005 | 3 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2006 | 7264 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 18 | 0.070 |
Why?
|
| Lac Operon | 1 | 2005 | 54 | 0.070 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 88 | 0.070 |
Why?
|
| Doxycycline | 1 | 2005 | 49 | 0.070 |
Why?
|
| Hemangiopericytoma | 1 | 2004 | 5 | 0.060 |
Why?
|
| Hemianopsia | 1 | 2004 | 8 | 0.060 |
Why?
|
| Risk | 1 | 2006 | 563 | 0.060 |
Why?
|
| Horner Syndrome | 1 | 2004 | 8 | 0.060 |
Why?
|
| Ophthalmoplegia | 1 | 2004 | 20 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 226 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2005 | 88 | 0.060 |
Why?
|
| Ocular Motility Disorders | 1 | 2004 | 15 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2005 | 112 | 0.060 |
Why?
|
| Efferent Pathways | 1 | 2003 | 15 | 0.060 |
Why?
|
| Brimonidine Tartrate | 1 | 2003 | 13 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 237 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2003 | 31 | 0.060 |
Why?
|
| Orbital Pseudotumor | 1 | 2003 | 1 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 40 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 124 | 0.060 |
Why?
|
| Mutation | 2 | 2007 | 1213 | 0.060 |
Why?
|
| Recurrence | 2 | 1997 | 948 | 0.060 |
Why?
|
| Risk Factors | 3 | 2000 | 5719 | 0.060 |
Why?
|
| Military Personnel | 1 | 2006 | 220 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2003 | 39 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2003 | 81 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2003 | 78 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 114 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2006 | 1548 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 614 | 0.060 |
Why?
|
| Intraocular Pressure | 1 | 2003 | 143 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2004 | 127 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2006 | 880 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2004 | 2222 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 100 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 617 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1032 | 0.050 |
Why?
|
| Ophthalmoscopy | 2 | 2001 | 13 | 0.050 |
Why?
|
| Aspirin | 1 | 2003 | 295 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2001 | 40 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2001 | 19 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 648 | 0.050 |
Why?
|
| Exons | 1 | 2001 | 122 | 0.050 |
Why?
|
| Adolescent | 3 | 2000 | 8903 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2001 | 76 | 0.050 |
Why?
|
| Age of Onset | 1 | 2001 | 188 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 239 | 0.050 |
Why?
|
| DNA Primers | 1 | 2001 | 302 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2001 | 54 | 0.050 |
Why?
|
| Macula Lutea | 1 | 2001 | 6 | 0.050 |
Why?
|
| Retinal Artery Occlusion | 1 | 2001 | 7 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2001 | 24 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2077 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2004 | 328 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2000 | 55 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2000 | 55 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 371 | 0.050 |
Why?
|
| Child | 3 | 2001 | 6400 | 0.050 |
Why?
|
| Models, Animal | 1 | 2001 | 252 | 0.050 |
Why?
|
| Homocysteine | 1 | 2000 | 26 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 514 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 1329 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2003 | 234 | 0.040 |
Why?
|
| Kidd Blood-Group System | 1 | 1999 | 1 | 0.040 |
Why?
|
| Color Perception | 1 | 1999 | 9 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 497 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 56 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2000 | 714 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 2790 | 0.040 |
Why?
|
| Retinal Vessels | 2 | 2009 | 74 | 0.040 |
Why?
|
| Electronystagmography | 1 | 1998 | 2 | 0.040 |
Why?
|
| Eye Movements | 1 | 1998 | 44 | 0.040 |
Why?
|
| Electroretinography | 1 | 1998 | 122 | 0.040 |
Why?
|
| Prolactinoma | 1 | 1997 | 1 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 778 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2001 | 364 | 0.040 |
Why?
|
| United States | 3 | 2009 | 7335 | 0.040 |
Why?
|
| Retinal Perforations | 1 | 1996 | 1 | 0.040 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 1996 | 2 | 0.040 |
Why?
|
| Scotoma | 1 | 1996 | 4 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1996 | 9 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 1996 | 18 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 18 | 0.040 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1996 | 19 | 0.040 |
Why?
|
| Trabeculectomy | 1 | 1996 | 5 | 0.040 |
Why?
|
| Dexamethasone | 1 | 1997 | 150 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 74 | 0.030 |
Why?
|
| Electron Probe Microanalysis | 1 | 1995 | 16 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 1996 | 43 | 0.030 |
Why?
|
| Cataract | 1 | 1997 | 134 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 1070 | 0.030 |
Why?
|
| Reoperation | 1 | 1997 | 467 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 351 | 0.030 |
Why?
|
| Disease Progression | 2 | 2009 | 1037 | 0.030 |
Why?
|
| Lenses, Intraocular | 1 | 1996 | 96 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2009 | 848 | 0.030 |
Why?
|
| Uveitis, Posterior | 1 | 1994 | 1 | 0.030 |
Why?
|
| Phlebitis | 1 | 1994 | 4 | 0.030 |
Why?
|
| Retinal Vein | 1 | 1994 | 4 | 0.030 |
Why?
|
| Calcinosis | 1 | 1995 | 241 | 0.030 |
Why?
|
| Optic Disk | 1 | 1994 | 37 | 0.030 |
Why?
|
| Mice | 1 | 2005 | 8472 | 0.030 |
Why?
|
| Mitochondria | 1 | 1997 | 643 | 0.030 |
Why?
|
| Calcium | 1 | 1995 | 929 | 0.030 |
Why?
|
| Pregnancy | 1 | 1997 | 2331 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1998 | 3185 | 0.020 |
Why?
|
| Inflammation | 1 | 1997 | 1030 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1996 | 2453 | 0.020 |
Why?
|
| Infant | 1 | 1996 | 2891 | 0.020 |
Why?
|
| Ranibizumab | 1 | 2009 | 3 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 3256 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 172 | 0.020 |
Why?
|
| Developing Countries | 1 | 2009 | 106 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2009 | 151 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 579 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2009 | 328 | 0.020 |
Why?
|
| Smallpox Vaccine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Hepatitis B Vaccines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 56 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1997 | 7028 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 546 | 0.020 |
Why?
|
| Prednisone | 1 | 2003 | 104 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 1419 | 0.010 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2001 | 1 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2550 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 2001 | 33 | 0.010 |
Why?
|
| Arterioles | 1 | 2001 | 40 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 2001 | 57 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2004 | 458 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2000 | 12 | 0.010 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2000 | 39 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 2000 | 7 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2000 | 88 | 0.010 |
Why?
|
| Edema | 1 | 2000 | 66 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2000 | 134 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 4655 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5708 | 0.010 |
Why?
|
| Macrophages | 1 | 2000 | 647 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2323 | 0.010 |
Why?
|